PHARMA

PHARMA

PHARMA

PHARMAPHARMA

PHARMA

LPPEssential MedicinesAPIFINANCINGR+DRegualators Quality Quality

LPPEssential Medicines

APIFINANCINGR+DRegualators Quality Quality

LPPEssential MedicinesAPIFINANCINGR+DRegualators Quality Quality

africa Pharmaconference 2020Enabling REgional Hubs foR incREasEd accEss to PHaRma and HEaltH commoditiEs

Date: June 8th - 9th, 2020 | Venue: nairobi

: dfs@developmentfinancesummit.com

: dfsafrica_ : Africa_dfs : DFSAfrica

Hosted By:

: AUDA NEPAD : AUDA_NEPAD

: NEPAD_Agency : AUDA_AGENCY

www.africapharmaconf.com

concePT noTe

africa pharma conference 2020 | concepT noTe 11

concEPt notE

tablE of contEnts

CONTEXT

OBJECTIVES

DELIVERABLES

PARTICIPATION

AGENDA

SIDE EVENTS

METHODOLOGY

DOCUMENTATION

DATE AND VENUE

WORKING LANGUAGES

3

6

7

7

8

9

10

10

10

10

africa pharma conference 2020 | concepT noTe africa pharma conference 2020 | concepT noTe 23

contEXt

african leaders seek to facilitate the creation of an enabling environment where every person has the opportunity to optimize their development potential. as the continent continues to grow such opportunities across several fronts, challenges remain to be fully surmounted in a host of key sectors. health status of africans remain sub-optimal and the health care delivery systems at national level are yet to be as efficient and accessible as required to provide for the sustainable delivery of testing, diagnostic, treatment and support services to the highest attainable standard of health.

The continent bears a significant burden of infectious diseases and non-communicable diseases, with huge unmet needs for Family Planning and other reproductive health commodities. outbreaks of emerging infectious diseases such as the recent ebola pandemic has further underscored the need to respond rapidly. access to medicines for many infectious and non-communicable diseases, nevertheless remains low across africa in addition to weaknesses in the supply chain systems.

this consequently creates an opportunity for pharmaceutical companies (and allied firms) to increase their presence and partner with local manufacturing companies to gain access into the market and expand their activities, while national governments reduce their dependency on donors and facilitate a more secure supply of these essential products.

The Africa Pharma Conference in Nairobi (2020) will focus on issues and policies that will facilitate sustainable development of regional hubs in best practices. ideas and initiatives around regional centers of excellence will be explored and this will constitute the foundation required for increased access to financial investments, technology and

cross-continental capacity development for the pharmaceutical sector and allied ecosystem. the pharmaceutical industry in africa is one of the fastest growing in the world. in past ten years the market has exploded to uS$ 21 billion, with projected estimate of uS$60 billion by the end of 2020; hence the focus on building regional clusters that will accentuate the growth of the african market is imperative.

rapid urbanization and increase in lifestyle diseases is another reason why regional clusters of excellence is crucial to africa’s desire to catalyze local manufacturing of essential medicines. as discretionary income continue to rise across africa, there will be a need to expand healthcare, governments’ incentives in healthcare, access to prescription and availability of generic medicine and medical devices. the smartest way for african communities to understand, analyze and catalyze this projected growth will be to understand the

growth through the prism of regional and local understanding of needs and solutions. this desire to optimize africa’s pharmaceutical ecosystem through regional development, will not be possible if challenges such as policy and regulation incoherence, shortage of specialists, weak quality regulatory agencies and fragmented markets are not addressed.

african leaders have previously established political commitments, including the Pharmaceutical Manufacturing Plan for africa and its related business Plan, the african Medicines regulatory Harmonization (AMRH) Programme led by the nePaD Planning and Coordinating agency, and the au roadmap on Global Solidarity and Shared responsibility. Furthermore, the continents leaders are firmly committed to industrial development as articulated in the au accelerated industrial Development Plan for Africa (AIDA). These need to be fully developed and implemented.

it is therefore imperative that the continent streamline and harmonize local and regional regulations, integrate markets, incentivize business environment to facilitate the operation of potential investors. This fits well within the framework of the action Plan for the accelerated industrial Development of Africa (AIDA) which seeks to facilitate an acceleration of industrial development (on the continent) and diversification of the economy to meet the challenges of (sustainable) development.

experience and knowledge needs to be shared between countries, within industries, and across the range of stakeholders. the challenges and opportunities need to be identified and addressed, and the political commitment across the continent harnessed in a structured manner. Private sector actors from the finance institutions, health care service providers and (international and local) pharmaceutical manufacturers (including medical

4

africa pharma conference 2020 | concepT noTe africa pharma conference 2020 | concepT noTe 1 25 6

devices and diagnostics) must develop mutually beneficial partnerships.

in September 2017, african union leaders, un Principals, representatives of international finance institutions and private sector actors reaffirmed their commitment to a broad-based international partnership to industrialize africa in a socially inclusive and environmentally sustainable manner through the un General assembly’s declaration of 2016-2025 as the third industrial Development Decade for Africa (IDDA III).

Consequently, the african union Development agency known as auDa-nePaD, african union Commission (AUC), and key stakeholders including the Consortium of Partners (in support of the PMPA) will convene annually for the Africa Pharma Conference. this conference is a high-level, pan-african forum on improving access to essential medicines and facilitating local production. the

inaugural session of the conference was held in Johannesburg South africa in June 2019 where, amongst other recommendations, auC, nePaD, reCs and FaPMa agreed to implement concrete strategies and policies that will ensure that african Pharma companies supply at least 50% of the essential medicines requirements within a decade.

to this end, the africa Pharma Conference 2020 will focus on establishing clear priorities for specific, coordinated and effective actions as well as business-to-business Platforms with support and commitment of senior policy makers to realize the vision of the african heads of State and Government and enable regional economic Communities in increasing access to Pharmaceuticals and health commodities. the second edition of the africa Pharma Conference will take place in nairobi on the 8th and 9th of June 2020.

the outcomes of the forum will be presented to the african union organs, such as the assembly of heads of State and Government for consideration.

obJEctiVEs

the overall aim of the conference is to facilitate concrete actions that will improve universal access to quality-assured affordable essential medicines and catalyze local production in Africa by harnessing high-level political commitment and workable solutions.

the forum will;

● examine the evidence as it relates to constraints and how to overcome them, opportunities and propose a number of concrete steps that can be implemented by governments to develop LPP;

● Consider a broad range of related issues including those of harmonization of regulatory protocols, research and development, production, quality control, distribution, testing and diagnosis and health care capacity development, as well as incentives that can boost local production on the african continent such as the african Medicines agency and other health systems initiatives;

● examine the way global pharmaceutical

companies can partner with african LPP’s to share knowledge, capacity development, technology and financing;

● Facilitate and forge business to business partnerships;

● Seek to support african regional economic Communities and countries to craft strategies that ensures increased access to Pharmaceuticals and health commodities;

● Discuss existing best practices employed by successful hubs for increased access to pharmaceuticals and how less successful hubs can leverage;

● articulate a set of recommended actions;

dEliVERablEs PaRticiPation

Participants and delegates to the Conference will include;

heads of State

Senior Government Officials such as Line Ministers; (health, industry, trade, Finance etc.);

Regional Economic Communities (RECs) i.e. eCoWaS, SaDC, CoMeSa, aMu, eaC, eCCaS,

Private Sector – Pharmaceutical companies, Pharmaceutical trade associations (e.g. FAPMA, IFPMA) and companies, Medical Device and Diagnostics manufacturers; investment and Finance Institutions; Logistics firms; etc.

uSP / uSaiD

Global Public health institutions (Global Fund, PEPFAR, UNITAID, MPP etc.)

national Medicines regulatory. authorities,

united nations agencies;

African) Academic and Research institutions;

Civil Society;

Donors and Development partners;

regional and international Finance institutions

i.ii.

iii.

iV.

V.

Vi. Vii.

Viii.iX.

X.Xi.Xii.

these will include:

Unified African leadership, working with pharmaceutical companies, business leaders and other stakeholders towards establishing a viable african pharmaceutical industry.

enhanced understanding of short- and longer-term opportunities for cost reductions, through procurement practices in order to ensure affordable and sustainable supplies of essential medicines.

Identification of opportunities to expand national and regional capacity to scale up pharmaceutical manufacturing across africa through:

i. improved procurement

ii. innovative service delivery

iii. expanded research and development, and

iv. Streamlined, coordinated and cooperative regulatory capabilities’

v. Appropriate financial incentives and tax options;

Strengthened platforms for triangular collaboration (north-South and South-South) as well as Business to Business partnerships.

i.

ii.

iii.

iV.

agEnda

The high level conference will run for three (4) days and the agenda will address amongst others;

Policy coherence (across sectors),

health Sector imperatives such as universal health Coverage (UHC), Maternal and Child Health,

African Medicines Agency (AMA) and Regulation,

Market integration,

Volume guarantees and incentives,

Good Manufacturing Practices (GMP),

Medical Devices and allied products,

Leveraging technology and artificial intelligence,

Pharmaceutical Financing Strategy,

Catalyzing Research and Development (R &D),

Strengthening Market intelligence and evidence base,

Supply Chain Management System (SCMS),

business facilitation and investment Promotion,

triPS Flexibilities,

africa CDC and humanitarian context

Leveraging the african Diaspora,

South-South and triangular Cooperation,

infrastructure and multi-sectoral factors, including human resources development;

1.2.

3.4.5.

6. 7.8.9.10.11.

12.13.14.15.16.17.18.

africa pharma conference 2020 | concepT noTe africa pharma conference 2020 | concepT noTe 1 287

mEtHodologY

the Conference will be organized to include didactic technical sessions; high level plenary sessions as well as focused thematic events.

documEntation

reference documents – will include but not limited to;

datE and VEnuE

Date: 8th - 9th of June 2020

Venue: nairobi, Kenya

WoRKing languagEs

english and French will be the working languages of the conference.

For further information, please contact;

Situational analysis of current practices in ensuring affordable and sustainable drug supply across africa, focusing on challenges and best practices, including incentive package to boost private sector investment;

Policy briefs on selected interventions that promote local production;

Synopsis on the business Plan of the PMPa Summary reports of related research and generated evidence;

business Plan for the operationalization of the Pharmaceutical Manufacturing Plan for africa;

background document on establishment of Fund for african Pharmaceutical Development;

action Plan for the accelerated industrial Development of Africa (AIDA);

Declaration of un General assembly on third industrial Development Decade for Africa (IDDA III);

1.

2.

3.

4.

5.

6.

7.Dr Janet byaruhanga; Senior Program Officer; NEPAD; Janetb@nepad.org

Dr. Djoudalbaye benjamin; head of Policy and health Diplomacy at africa Centres for Disease Control and Prevention; auC benjaminD@africa-union.org

Mr bankole eniola; executive Director, DFS africa; bankole@developmentfinancesummit.com

1.

2.

3.

africa pharma conference 2020 | concepT noTe africa pharma conference 2020 | concepT noTe 1 2

sidE EVEnts

the Conference will be organized in parallel to the following side events:

the Deal room at aPC 2020 will connect african pharmaceutical manufacturing and packaging companies to a global pool of financing organizations that include; impact investors, Private equity Funds, investment companies and Development Finance Institutions (DFIs). The model of the Deal room is to match vetted, relevant and development-focused high growth Pharma businesses in africa to the right partnerships that can help them to scale; thereby providing the right financing, technological and capacity development support.

the board room at aPC 2020 is a 2-hour session that brings together 12-14 principal stakeholders within the Pharma ecosystem to deliberate on critical topics affecting the pharma value chain. each board room session will consist of the following stakeholders: Minister of health/Finance/trade [Governments], top executive of a big-Pharma company, investors, research and development, Local manufacturers, Key opinion Leaders, technology providers and Media. this is an invite only session.

the boot Camp at aPC 2020 will hold for two days preceding the conference. the boot camp will be in partnership with Wharton business School, Who and uniCeF. the training sessions will focus on equipping the participants (LPPs) with critical skills required in the Pharma value chain. Some of the topics to be considered during the aPC 2020 boot camp will include: Procurement, Supply chain, creating lean and efficient business models etc. Participants of the boot camp will be awarded a certificate of participation at the end of the boot camp.

1. dEal Room: 2. boaRd Room: 3. boot camP:

109

PMPAPharmaceutical Manufacturing Plan for Africa